Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Performance and trend for quality of service in a large HIV/AIDS treatment program in Nigeria.

Aliyu A, El-Kamary S, Brown J, Agins B, Ndembi N, Aliyu G, Jumare J, Adelekan B, Dakum P, Abimiku A, Charurat M.

AIDS Res Ther. 2019 Oct 1;16(1):29. doi: 10.1186/s12981-019-0242-2. Review.

2.

Blueprint for building a biorepository in a resource-limited setting that follows international best practices.

Abimiku AG, Croxton T, Ozumba PJ, Agala N, Balogun O, Jonathan E, Onyemata E, Ndifon K, Nadoma S, Anazodo T, Peters S, Beiswanger CM.

Afr J Lab Med. 2019 Aug 28;8(1):722. doi: 10.4102/ajlm.v8i1.722. eCollection 2019.

3.

Missed opportunities for early infant diagnosis of HIV in rural North-Central Nigeria: A cascade analysis from the INSPIRE MoMent study.

Anaba UC, Sam-Agudu NA, Ramadhani HO, Torbunde N, Abimiku A, Dakum P, Aliyu SH, Charurat M.

PLoS One. 2019 Jul 31;14(7):e0220616. doi: 10.1371/journal.pone.0220616. eCollection 2019.

4.

Prevalence of hypertension among patients aged 50 and older living with human immunodeficiency virus.

Dakum P, Kayode GA, Abimiku A, Avong YK, Okuma J, Onyemata E, Ali T, Adekanmbi V, Uthman O.

Medicine (Baltimore). 2019 Apr;98(15):e15024. doi: 10.1097/MD.0000000000015024.

5.

TLR10 Senses HIV-1 Proteins and Significantly Enhances HIV-1 Infection.

Henrick BM, Yao XD, Zahoor MA, Abimiku A, Osawe S, Rosenthal KL.

Front Immunol. 2019 Mar 15;10:482. doi: 10.3389/fimmu.2019.00482. eCollection 2019.

6.

HIV Viral Dynamics of Lopinavir/Ritonavir Monotherapy as Second-Line Treatment: A Prospective, Single-Arm Trial.

Claassen CW, Keckich D, Nwizu C, Abimiku A, Salami D, Obiefune M, Gilliam BL, Amoroso A.

J Int Assoc Provid AIDS Care. 2019 Jan-Dec;18:2325958218823209. doi: 10.1177/2325958218823209.

PMID:
30798695
7.

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study.

Zürcher K, Ballif M, Fenner L, Borrell S, Keller PM, Gnokoro J, Marcy O, Yotebieng M, Diero L, Carter EJ, Rockwood N, Wilkinson RJ, Cox H, Ezati N, Abimiku AG, Collantes J, Avihingsanon A, Kawkitinarong K, Reinhard M, Hömke R, Huebner R, Gagneux S, Böttger EC, Egger M; International epidemiology Databases to Evaluate AIDS (IeDEA) consortium.

Lancet Infect Dis. 2019 Mar;19(3):298-307. doi: 10.1016/S1473-3099(18)30673-X. Epub 2019 Feb 8.

8.

Cost of three models of care for drug-resistant tuberculosis patients in Nigeria.

Bada FO, Okpokoro E, Blok N, Meribole E, Dutt S, Dakum P, Abimiku A, Zwerling A, Kik SV.

BMC Infect Dis. 2019 Jan 10;19(1):41. doi: 10.1186/s12879-018-3636-1.

9.

The role of connected diagnostics in strengthening regional, national and continental African disease surveillance.

Gous NM, Onyebujoh PC, Abimiku A, Macek C, Takle J.

Afr J Lab Med. 2018 Dec 6;7(2):775. doi: 10.4102/ajlm.v7i2.775. eCollection 2018. No abstract available.

10.

Brief Report: Body Mass Index and Cognitive Function Among HIV-1-Infected Individuals in China, India, and Nigeria.

Jumare J, El-Kamary SS, Magder L, Hungerford L, Umlauf A, Franklin D, Ghate M, Abimiku A, Charurat M, Letendre S, Ellis RJ, Mehendale S, Blattner WA, Royal W 3rd, Marcotte TD, Heaton RK, Grant I, McCutchan JA.

J Acquir Immune Defic Syndr. 2019 Feb 1;80(2):e30-e35. doi: 10.1097/QAI.0000000000001906.

PMID:
30422905
11.

Compromised Growth Among HIV-exposed Uninfected Compared With Unexposed Children in Nigeria.

Jumare J, Datong P, Osawe S, Okolo F, Mohammed S, Inyang B, Abimiku A; INFANT Study Team.

Pediatr Infect Dis J. 2019 Mar;38(3):280-286. doi: 10.1097/INF.0000000000002238.

PMID:
30418356
12.

Development, Evaluation, and Implementation of a Pan-African Cancer Research Network: Men of African Descent and Carcinoma of the Prostate.

Andrews C, Fortier B, Hayward A, Lederman R, Petersen L, McBride J, Petersen DC, Ajayi O, Kachambwa P, Seutloali M, Shoko A, Mokhosi M, Hiller R, Adams M, Ongaco C, Pugh E, Romm J, Shelford T, Chinegwundoh F, Adusei B, Mante S, Snyper NY, Agalliu I, Lounsbury DW, Rohan T, Orfanos A, Quintana Y, Jacobson JS, Neugut AI, Gelmann E, Lachance J, Dial C, Diallo TA, Jalloh M, Gueye SM, Kane PMS, Diop H, Ndiaye AJ, Sall AS, Toure-Kane NC, Onyemata E, Abimiku A, Adjei AA, Biritwum R, Gyasi R, Kyei M, Mensah JE, Okine J, Okyne V, Rockson I, Tay E, Tettey Y, Yeboah E, Chen WC, Singh E, Cook MB, Duffy CN, Hsing A, Soo CC, Fernandez P, Irusen H, Aisuodionoe-Shadrach O, Jamda AM, Olabode PO, Nwegbu MM, Ajibola OH, Ajamu OJ, Ambuwa YG, Adebiyi AO, Asuzu M, Ogunbiyi O, Popoola O, Shittu O, Amodu O, Odiaka E, Makinde I, Joffe M, Pentz A, Rebbeck TR.

J Glob Oncol. 2018 Sep;4:1-14. doi: 10.1200/JGO.18.00063.

13.

Demography and the dual epidemics of tuberculosis and HIV: Analysis of cross-sectional data from Sub-Saharan Africa.

Aliyu G, El-Kamary SS, Abimiku A, Blattner W, Charurat M.

PLoS One. 2018 Sep 7;13(9):e0191387. doi: 10.1371/journal.pone.0191387. eCollection 2018.

14.

Plasma HIV RNA level is associated with neurocognitive function among HIV-1-infected patients in Nigeria.

Jumare J, El-Kamary SS, Magder L, Hungerford L, Ndembi N, Aliyu A, Dakum P, Umlauf A, Cherner M, Abimiku A, Charurat M, Blattner WA, Royal W 3rd.

J Neurovirol. 2018 Dec;24(6):712-719. doi: 10.1007/s13365-018-0667-8. Epub 2018 Aug 30.

15.

Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ era.

Tchakoute CT, Sainani KL, Osawe S, Datong P, Kiravu A, Rosenthal KL, Gray CM, Cameron DW, Abimiku A, Jaspan HB; INFANT study team.

AIDS. 2018 Oct 23;32(16):2383-2391. doi: 10.1097/QAD.0000000000001974.

PMID:
30134300
16.

Addressing the under-reporting of adverse drug reactions in public health programs controlling HIV/AIDS, Tuberculosis and Malaria: A prospective cohort study.

Avong YK, Jatau B, Gurumnaan R, Danat N, Okuma J, Usman I, Mordi D, Ukpabi B, Kayode GA, Dutt S, El-Tayeb O, Afolabi B, Ambrose I, Agbaji O, Osakwe A, Ibrahim A, Ogar C, Nosiri H, Avong EB, Adekanmbi V, Uthman O, Abimiku A, Oni YO, Mensah CO, Dakum P, Mberu KE, Ogundahunsi OAT.

PLoS One. 2018 Aug 22;13(8):e0200810. doi: 10.1371/journal.pone.0200810. eCollection 2018.

17.

Laboratory medicine in Africa since 2008: then, now, and the future.

Nkengasong JN, Mbopi-Keou FX, Peeling RW, Yao K, Zeh CE, Schneidman M, Gadde R, Abimiku A, Onyebujoh P, Birx D, Hader S.

Lancet Infect Dis. 2018 Nov;18(11):e362-e367. doi: 10.1016/S1473-3099(18)30120-8. Epub 2018 Jul 3. Review.

PMID:
29980383
18.

H3Africa: current perspectives.

Mulder N, Abimiku A, Adebamowo SN, de Vries J, Matimba A, Olowoyo P, Ramsay M, Skelton M, Stein DJ.

Pharmgenomics Pers Med. 2018 Apr 10;11:59-66. doi: 10.2147/PGPM.S141546. eCollection 2018. Review.

19.

Cognitive Function Among Antiretroviral Treatment-Naive Individuals Infected With Human Immunodeficiency Virus Type 1 Subtype G Versus CRF02_AG in Nigeria.

Jumare J, Ndembi N, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Dakum P, Umlauf A, Cherner M, Abimiku A, Charurat M, Blattner WA, Royal W 3rd.

Clin Infect Dis. 2018 Apr 17;66(9):1448-1453. doi: 10.1093/cid/cix1019.

20.

Diagnostic system strengthening for drug resistant tuberculosis in Nigeria: impact and challenges.

Aliyu G, Ezati N, Iwakun M, Peters S, Abimiku A.

Afr J Lab Med. 2017 Mar 31;6(2):502. doi: 10.4102/ajlm.v6i2.502. eCollection 2017.

21.

Assuring the quality of diagnostic testing: The future is now.

Nkengsong J, Boeras DI, Abimiku A, Peeling RW.

Afr J Lab Med. 2016 Oct 17;5(2):558. doi: 10.4102/ajlm.v5i2.558. eCollection 2016. No abstract available.

22.

Implementing quality assurance for laboratory-based and point-of-care HIV testing in Nigeria.

Abubakar A, Peters S, Balogun O, Osawe S, Mamman I, Barde J, Ojo E, Ezati N, Bango J, Ngige E, Emeribe A, Abimiku A.

Afr J Lab Med. 2016 Oct 17;5(2):455. doi: 10.4102/ajlm.v5i2.455. eCollection 2016. No abstract available.

23.

A23 Identification of HIV drug resistance mutation patterns using illumina MiSeq next generation sequencing in patients failing second-line boosted protease inhibitor therapy in Nigeria.

James OE, Johanna L, Rawlings D, Babajehson M, Ashrad I, Anne D, Abimiku A, Dakum P, Gillian H, Ndembi N.

Virus Evol. 2017 Mar 5;3(Suppl 1). pii: vew036.022. doi: 10.1093/ve/vew036.022. eCollection 2017 Mar. No abstract available.

24.

Closing the NIH Fogarty Center threatens US and global health.

Karim SSA, Karim QA, Abimiku A, Bekker LG, Bukusi EA, Deschamps MMH, Derbew M, Garcia PJ, Gray G, Kamya MR, Swaminathan S, Wu Z.

Lancet. 2017 Jul 29;390(10093):451. doi: 10.1016/S0140-6736(17)31912-8. Epub 2017 Jul 27. No abstract available.

25.

Erratum to: Barriers to and Facilitators of Adherence to Exclusive Breastfeeding Practices Among HIV Infected and Non-Infected Women in Jos, Nigeria.

Coetzee B, Tomlinson M, Osawe S, Abimiku A, Kagee A; INFANT Study Team.

Matern Child Health J. 2017 Jul;21(7):1589. doi: 10.1007/s10995-017-2294-z. No abstract available.

PMID:
28293763
26.

Peripheral blood lymphocyte HIV DNA levels correlate with HIV associated neurocognitive disorders in Nigeria.

Jumare J, Sunshine S, Ahmed H, El-Kamary SS, Magder L, Hungerford L, Burdo T, Eyzaguirre LM, Umlauf A, Cherner M, Abimiku A, Charurat M, Li JZ, Blattner WA, Royal W 3rd.

J Neurovirol. 2017 Jun;23(3):474-482. doi: 10.1007/s13365-017-0520-5. Epub 2017 Feb 27.

27.

Sustainable clinical laboratory capacity for health in Africa.

Davies J, Abimiku A, Alobo M, Mullan Z, Nugent R, Schneidman M, Sikhondze W, Onyebujoh P.

Lancet Glob Health. 2017 Mar;5(3):e248-e249. doi: 10.1016/S2214-109X(17)30024-4. Epub 2017 Jan 18. No abstract available.

28.

Barriers to and Facilitators of Adherence to Exclusive Breastfeeding Practices Among HIV Infected and Non-Infected Women in Jos, Nigeria.

Coetzee B, Tomlinson M, Osawe S, Abimiku A, Kagee A; INFANT Study Team.

Matern Child Health J. 2017 Apr;21(4):953-960. doi: 10.1007/s10995-016-2253-0. Erratum in: Matern Child Health J. 2017 Jul;21(7):1589. Amibiku, Alash'le [corrected to Abimiku, Alash'le].

29.

A Decade of Monitoring HIV Epidemics in Nigeria: Positioning for Post-2015 Agenda.

Akinwande O, Bashorun A, Azeez A, Agbo F, Dakum P, Abimiku A, Bilali C, Idoko J, Ogungbemi K.

AIDS Behav. 2017 Jul;21(Suppl 1):62-71. doi: 10.1007/s10461-016-1603-7.

PMID:
27844297
30.

Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring.

Peter T, Ellenberger D, Kim AA, Boeras D, Messele T, Roberts T, Stevens W, Jani I, Abimiku A, Ford N, Katz Z, Nkengasong JN.

Lancet Infect Dis. 2017 Jan;17(1):e26-e29. doi: 10.1016/S1473-3099(16)30212-2. Epub 2016 Oct 20. Review.

31.

Laboratory Innovation Towards Quality Program Sustainability.

Abimiku A, Timperi R, Blattner W.

Curr HIV/AIDS Rep. 2016 Aug;13(4):202-8. doi: 10.1007/s11904-016-0323-y. Review.

PMID:
27485836
32.

Development of a prospective cohort of HIV Exposed Sero-Negative (HESN) individuals in Jos Nigeria.

Osawe S, Okpokoro E, Datiri R, Choji G, Okolo F, Datong P, Abimiku A.

BMC Infect Dis. 2016 Jul 22;16:352. doi: 10.1186/s12879-016-1649-1.

33.

Active tracking of rejected dried blood samples in a large program in Nigeria.

Inalegwu A, Phillips S, Datir R, Chime C, Ozumba P, Peters S, Ogbanufe O, Mensah C, Abimiku A, Dakum P, Ndembi N.

World J Virol. 2016 May 12;5(2):73-81. doi: 10.5501/wjv.v5.i2.73.

34.

Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.

Royal W 3rd, Cherner M, Burdo TH, Umlauf A, Letendre SL, Jumare J, Abimiku A, Alabi P, Alkali N, Bwala S, Okwuasaba K, Eyzaguirre LM, Akolo C, Guo M, Williams KC, Blattner WA.

PLoS One. 2016 Feb 1;11(2):e0147182. doi: 10.1371/journal.pone.0147182. eCollection 2016.

35.

Socio-Demographic and Adherence Factors Associated with Viral Load Suppression in HIV-Infected Adults Initiating Therapy in Northern Nigeria: A Randomized Controlled Trial of a Peer Support Intervention.

Coker M, Etiebet MA, Chang H, Awwal G, Jumare J, Musa BM, Babashani M, Habib AG, Dakum P, Abimiku AG, Charurat ME, Blattner WA, Eng M, Ndembi N.

Curr HIV Res. 2015;13(4):279-85.

PMID:
25845393
36.

Performance of Genotype MTBDRplus in the Detection of Resistance to Rifampicin and Isoniazid Among Clinical Mycobacteria Isolates in Ilorin, Nigeria.

Nwofor AC, Nyamngee A, Nwabuisi C, Iwakun M, Gidado M, Mensah C, Dakum P, Agbede OO, Ndembi N, Blattner WA, Abimiku AG.

Curr HIV Res. 2015;13(4):308-14.

PMID:
25845392
37.

Doing no harm? Adverse events in a nation-wide cohort of patients with multidrug-resistant tuberculosis in Nigeria.

Avong YK, Isaakidis P, Hinderaker SG, Van den Bergh R, Ali E, Obembe BO, Ekong E, Adebamowo C, Ndembi N, Okuma J, Osakwe A, Oladimeji O, Akang G, Obasanya JO, Eltayeb O, Agbaje AV, Abimiku A, Mensah CO, Dakum PS.

PLoS One. 2015 Mar 17;10(3):e0120161. doi: 10.1371/journal.pone.0120161. eCollection 2015.

38.

Adherence to Anti-Retroviral Therapy in North Central Nigeria.

Avong YK, van Wyk B, Njab J, Abimiku AG, Ndembi N, Okuma J, Ogbanufe O, Ekong E, Dakum P, Blattner WA.

Curr HIV Res. 2015;13(4):268-78.

PMID:
25642849
39.

Improved Performance of COBAS AmpliPrep/COBAS TaqMan Version 2.0 Assay Over Amplicor Monitor Version 1.5 in the Quantification of HIV-1 RNA Viral Load in Abuja, Nigeria.

Abubakar A, Ndembi N, Ogbanufe O, Inalegwu A, Wilson S, Ebagua I, Peters S, Chime C, Dakum P, Abimiku AG.

Curr HIV Res. 2015;13(4):262-7.

PMID:
25613132
40.

Long-term outcome of second-line antiretroviral therapy in resource-limited settings.

Osinusi-Adekanmbi O, Stafford K, Ukpaka A, Salami D, Ajayi S, Ndembi N, Abimiku A, Nwizu C, Gilliam B, Redfield R, Amoroso A.

J Int Assoc Provid AIDS Care. 2014 Jul-Aug;13(4):366-71.

PMID:
25513035
41.

Cost-effectiveness of point-of-care digital chest-x-ray in HIV patients with pulmonary mycobacterial infections in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Hungerford L, Obasanya J, Blattner W.

BMC Infect Dis. 2014 Dec 13;14:675. doi: 10.1186/s12879-014-0675-0.

42.

Update on HIV-1 acquired and transmitted drug resistance in Africa.

Ssemwanga D, Lihana RW, Ugoji C, Abimiku A, Nkengasong J, Dakum P, Ndembi N.

AIDS Rev. 2015 Jan-Mar;17(1):3-20. Review.

PMID:
25427100
43.

Soluble toll-like receptor 2 is significantly elevated in HIV-1 infected breast milk and inhibits HIV-1 induced cellular activation, inflammation and infection.

Henrick BM, Yao XD, Drannik AG, Abimiku A, Rosenthal KL; INFANT Study Team.

AIDS. 2014 Sep 10;28(14):2023-32. doi: 10.1097/QAD.0000000000000381.

PMID:
25265071
44.

Research capacity. Enabling the genomic revolution in Africa.

H3Africa Consortium, Rotimi C, Abayomi A, Abimiku A, Adabayeri VM, Adebamowo C, Adebiyi E, Ademola AD, Adeyemo A, Adu D, Affolabi D, Agongo G, Ajayi S, Akarolo-Anthony S, Akinyemi R, Akpalu A, Alberts M, Alonso Betancourt O, Alzohairy AM, Ameni G, Amodu O, Anabwani G, Andersen K, Arogundade F, Arulogun O, Asogun D, Bakare R, Balde N, Baniecki ML, Beiswanger C, Benkahla A, Bethke L, Boehnke M, Boima V, Brandful J, Brooks AI, Brosius FC, Brown C, Bucheton B, Burke DT, Burnett BG, Carrington-Lawrence S, Carstens N, Chisi J, Christoffels A, Cooper R, Cordell H, Crowther N, Croxton T, de Vries J, Derr L, Donkor P, Doumbia S, Duncanson A, Ekem I, El Sayed A, Engel ME, Enyaru JC, Everett D, Fadlelmola FM, Fakunle E, Fischbeck KH, Fischer A, Folarin O, Gamieldien J, Garry RF, Gaseitsiwe S, Gbadegesin R, Ghansah A, Giovanni M, Goesbeck P, Gomez-Olive FX, Grant DS, Grewal R, Guyer M, Hanchard NA, Happi CT, Hazelhurst S, Hennig BJ, Hertz- C, Fowler, Hide W, Hilderbrandt F, Hugo-Hamman C, Ibrahim ME, James R, Jaufeerally-Fakim Y, Jenkins C, Jentsch U, Jiang PP, Joloba M, Jongeneel V, Joubert F, Kader M, Kahn K, Kaleebu P, Kapiga SH, Kassim SK, Kasvosve I, Kayondo J, Keavney B, Kekitiinwa A, Khan SH, Kimmel P, King MC, Kleta R, Koffi M, Kopp J, Kretzler M, Kumuthini J, Kyobe S, Kyobutungi C, Lackland DT, Lacourciere KA, Landouré G, Lawlor R, Lehner T, Lesosky M, Levitt N, Littler K, Lombard Z, Loring JF, Lyantagaye S, Macleod A, Madden EB, Mahomva CR, Makani J, Mamven M, Marape M, Mardon G, Marshall P, Martin DP, Masiga D, Mason R, Mate-Kole M, Matovu E, Mayige M, Mayosi BM, Mbanya JC, McCurdy SA, McCarthy MI, McIlleron H, Mc'Ligeyo SO, Merle C, Mocumbi AO, Mondo C, Moran JV, Motala A, Moxey-Mims M, Mpoloka WS, Msefula CL, Mthiyane T, Mulder N, Mulugeta Gh, Mumba D, Musuku J, Nagdee M, Nash O, Ndiaye D, Nguyen AQ, Nicol M, Nkomazana O, Norris S, Nsangi B, Nyarko A, Nyirenda M, Obe E, Obiakor R, Oduro A, Ofori-Acquah SF, Ogah O, Ogendo S, Ohene-Frempong K, Ojo A, Olanrewaju T, Oli J, Osafo C, Ouwe Missi Oukem-Boyer O, Ovbiagele B, Owen A, Owolabi MO, Owolabi L, Owusu-Dabo E, Pare G, Parekh R, Patterton HG, Penno MB, Peterson J, Pieper R, Plange-Rhule J, Pollak M, Puzak J, Ramesar RS, Ramsay M, Rasooly R, Reddy S, Sabeti PC, Sagoe K, Salako T, Samassékou O, Sandhu MS, Sankoh O, Sarfo FS, Sarr M, Shaboodien G, Sidibe I, Simo G, Simuunza M, Smeeth L, Sobngwi E, Soodyall H, Sorgho H, Sow Bah O, Srinivasan S, Stein DJ, Susser ES, Swanepoel C, Tangwa G, Tareila A, Tastan Bishop O, Tayo B, Tiffin N, Tinto H, Tobin E, Tollman SM, Traoré M, Treadwell MJ, Troyer J, Tsimako-Johnstone M, Tukei V, Ulasi I, Ulenga N, van Rooyen B, Wachinou AP, Waddy SP, Wade A, Wayengera M, Whitworth J, Wideroff L, Winkler CA, Winnicki S, Wonkam A, Yewondwos M, sen T, Yozwiak N, Zar H.

Science. 2014 Jun 20;344(6190):1346-8. doi: 10.1126/science.1251546. No abstract available.

45.

Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.

Akolo C, Royal W 3rd, Cherner M, Okwuasaba K, Eyzaguirre L, Adebiyi R, Umlauf A, Hendrix T, Johnson J, Abimiku A, Blattner WA.

J Neurovirol. 2014 Aug;20(4):380-7. doi: 10.1007/s13365-014-0254-6. Epub 2014 Jun 14.

46.

Comprehensive reference ranges for hematology and clinical chemistry laboratory parameters derived from normal Nigerian adults.

Miri-Dashe T, Osawe S, Tokdung M, Daniel N, Choji RP, Mamman I, Deme K, Damulak D, Abimiku A.

PLoS One. 2014 May 15;9(5):e93919. doi: 10.1371/journal.pone.0093919. eCollection 2014. Erratum in: PLoS One. 2014;9(6):e100601. Daniel, Monday Tokdung Nenbammun [corrected to Tokdung, Monday]; [corrected to Daniel, Nenbammun].

47.

Long-term outcome of second-line antiretroviral therapy in resource-limited settings.

Osinusi-Adekanmbi O, Stafford K, Ukpaka A, Salami D, Ajayi S, Ndembi N, Abimiku A, Nwizu C, Gilliam B, Redfield R, Amoroso A.

J Int Assoc Provid AIDS Care. 2014 Jul-Aug;13(4):366-71.

PMID:
24668134
48.

Optimising Mycobacterium tuberculosis detection in resource limited settings.

Alfred N, Lovette L, Aliyu G, Olusegun O, Meshak P, Jilang T, Iwakun M, Nnamdi E, Olubunmi O, Dakum P, Abimiku A.

BMJ Open. 2014 Mar 3;4(3):e004093. doi: 10.1136/bmjopen-2013-004093.

49.

Mycobacterial Etiology of Pulmonary Tuberculosis and Association with HIV Infection and Multidrug Resistance in Northern Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Ezati N, Mosunmola I, Hungerford L, Brown C, Tracy KJ, Obasanya J, Blattner W.

Tuberc Res Treat. 2013;2013:650561. doi: 10.1155/2013/650561. Epub 2013 Jul 16.

50.

Prevalence of non-tuberculous mycobacterial infections among tuberculosis suspects in Nigeria.

Aliyu G, El-Kamary SS, Abimiku A, Brown C, Tracy K, Hungerford L, Blattner W.

PLoS One. 2013 May 9;8(5):e63170. doi: 10.1371/journal.pone.0063170. Print 2013.

Supplemental Content

Loading ...
Support Center